• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Ligand Pharmaceuticals Inc

+ Add to Watchlist

LGNYZ:US

0.0630 USD 0.00000.00%

As of 20:10:00 ET on 10/24/2014.

Snapshot for Ligand Pharmaceuticals Inc (LGNYZ)

Open: 0.0630 Day's Range: 0.0630 - 0.0630 Volume: 10,000
Previous Close: 0.0630 52wk Range: 0.0200 - 0.0939 1-Yr Rtn: +119.59%

Stock Chart for LGNYZ

No chart data available.
  • LGNYZ:US 0.0630
  • 1D
  • 1M
  • 1Y
0.0630
Interactive LGNYZ Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for LGNYZ

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 0.00
Shares Outstanding (M) 0.00
30 Day Average Volume 5,516
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 1.17%
Cash Dividend (USD) 0.0007
Dividend Ex-Date 07/10/2014
5 Year Dividend Growth -
Next Earnings Announcement 10/27/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for LGNYZ

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for LGNYZ

Ligand Pharmaceuticals Incorporated develops drugs which regulate hormone activated intracellular receptors. These receptors play a role in regulating the genetic processes affecting diseases such as gynecological disorders, certain cancers, as well as cardiovascular, inflammatory, and skin diseases.

John L HigginsPresident/CEOMatthew W Foehr "Matt"Exec VP/COO
Charles S BerkmanVP/Secretary/General CounselNishan De SilvaVP:Finance & Strategy/CFO
More Company Profile & Key Executives for LGNYZ

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil